Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Galaxy Biosolutions AB
AB
In liquidation
Org 5594516535
Göteborg
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2023
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Galaxy Biosolutions AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (5)
BJ
Bengt Junior Niklas Nygårds
External Signatory
External Signatory
2026
KO
Knut Olof Mikael Rosén
Liquidator
Liquidator
2026
AE
Anna Elisabet Viktoria Björk
External Signatory
External Signatory
2026
UM
Ulrika Margareta Ahlholm
External Signatory
External Signatory
2026
EJ
Emma Johanna Karin Carlstedt Haga
External Signatory
External Signatory
2026
Former (1)
KA
Karl Anders Teodor Fransson
Chief Executive Officer
Chief Executive Officer
2025 – 2026
Board of directors
Non-executive oversight
Name
Role
Member since
Former (4)
EK
Evelina K F Stoli Wängberg
Chairman
2023 – 2024
HD
Hanna D H Alalam
Chairman
2025 – 2026
KV
Kameshwara Venkata Ramana Peri
Board of Directors
2023 – 2026
GK
Georgia-Soultana Kourouklidou
Chairman
2024 – 2025
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Galaxy Biosolutions AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network